CA3002502A1 - Innovative preparation and crystallization of iosimenol - Google Patents

Innovative preparation and crystallization of iosimenol Download PDF

Info

Publication number
CA3002502A1
CA3002502A1 CA3002502A CA3002502A CA3002502A1 CA 3002502 A1 CA3002502 A1 CA 3002502A1 CA 3002502 A CA3002502 A CA 3002502A CA 3002502 A CA3002502 A CA 3002502A CA 3002502 A1 CA3002502 A1 CA 3002502A1
Authority
CA
Canada
Prior art keywords
iosimenol
crystal
group
crystallization
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA3002502A
Other languages
English (en)
French (fr)
Inventor
Jiri Malinak
Ivan Hlavacek
Jiri Prokop
Yoshito Masuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of CA3002502A1 publication Critical patent/CA3002502A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/005—Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/0081—Use of vibrations, e.g. ultrasound
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/08—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor
    • B01J19/10—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor employing sonic or ultrasonic vibrations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/08—Preparation of carboxylic acid amides from amides by reaction at nitrogen atoms of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/22—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/22—Separation; Purification; Stabilisation; Use of additives
    • C07C231/24—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/46—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having carbon atoms of carboxamide groups, amino groups and at least three atoms of bromine or iodine, bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D2009/0086—Processes or apparatus therefor
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00049—Controlling or regulating processes
    • B01J2219/00051—Controlling the temperature
    • B01J2219/00139—Controlling the temperature using electromagnetic heating
    • B01J2219/00141—Microwaves
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
CA3002502A 2015-11-04 2016-11-02 Innovative preparation and crystallization of iosimenol Abandoned CA3002502A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562250720P 2015-11-04 2015-11-04
US62/250,720 2015-11-04
PCT/JP2016/004798 WO2017077710A1 (en) 2015-11-04 2016-11-02 Innovative preparation and crystallization of iosimenol

Publications (1)

Publication Number Publication Date
CA3002502A1 true CA3002502A1 (en) 2017-05-11

Family

ID=57354423

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3002502A Abandoned CA3002502A1 (en) 2015-11-04 2016-11-02 Innovative preparation and crystallization of iosimenol

Country Status (23)

Country Link
US (1) US10544089B2 (https=)
EP (1) EP3371147B1 (https=)
JP (1) JP6778746B2 (https=)
KR (1) KR20180077198A (https=)
CN (1) CN108368031B (https=)
AU (2) AU2016350219B2 (https=)
CA (1) CA3002502A1 (https=)
CY (1) CY1124164T1 (https=)
DK (1) DK3371147T3 (https=)
ES (1) ES2873828T3 (https=)
HR (1) HRP20210820T1 (https=)
HU (1) HUE054876T2 (https=)
LT (1) LT3371147T (https=)
MY (1) MY186399A (https=)
NZ (1) NZ742104A (https=)
PH (1) PH12018500872A1 (https=)
PL (1) PL3371147T3 (https=)
PT (1) PT3371147T (https=)
SA (1) SA518391413B1 (https=)
SG (1) SG11201803241YA (https=)
SI (1) SI3371147T1 (https=)
TW (1) TWI724049B (https=)
WO (1) WO2017077710A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102128423B1 (ko) * 2018-09-17 2020-07-01 (주)유케이케미팜 조영제 이오메프롤의 제조방법
CN111777525B (zh) * 2019-04-04 2021-08-27 成都西岭源药业有限公司 一种碘克沙醇的精制方法
KR102179649B1 (ko) * 2019-10-11 2020-11-18 (주)에이에스텍 디에틸아미노하이드록시벤조일헥실벤조에이트의 제조 방법
CN115931935A (zh) * 2022-12-28 2023-04-07 深圳晶泰科技有限公司 一种提高微晶电子衍射数据质量的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698739A (en) 1989-07-05 1997-12-16 Schering Aktiengesellschaft Carboxamide non-ionic contrast media
US6072069A (en) * 1998-11-04 2000-06-06 Biophysica, Inc. Biodegradable nonionic contrast media
NO20053687D0 (no) * 2005-07-29 2005-07-29 Amersham Health As Crystallisation Process.
EP2240432B1 (en) 2008-01-14 2012-07-04 Mallinckrodt LLC Process for the preparation of iosimenol

Also Published As

Publication number Publication date
EP3371147A1 (en) 2018-09-12
AU2016350219A1 (en) 2018-05-17
TWI724049B (zh) 2021-04-11
JP6778746B2 (ja) 2020-11-04
CN108368031B (zh) 2022-05-03
DK3371147T3 (da) 2021-05-25
HUE054876T2 (hu) 2021-10-28
US20190177266A1 (en) 2019-06-13
HRP20210820T1 (hr) 2021-06-25
PL3371147T3 (pl) 2021-10-25
SG11201803241YA (en) 2018-05-30
AU2021205101B2 (en) 2022-11-24
WO2017077710A1 (en) 2017-05-11
MY186399A (en) 2021-07-22
SA518391413B1 (ar) 2022-03-06
EP3371147B1 (en) 2021-04-07
PH12018500872A1 (en) 2018-11-05
CN108368031A (zh) 2018-08-03
NZ742104A (en) 2023-01-27
SI3371147T1 (sl) 2021-08-31
LT3371147T (lt) 2021-08-10
US10544089B2 (en) 2020-01-28
HK1257821A1 (en) 2019-11-01
PT3371147T (pt) 2021-05-24
CY1124164T1 (el) 2022-05-27
TW201722906A (zh) 2017-07-01
AU2021205101A1 (en) 2021-08-19
KR20180077198A (ko) 2018-07-06
JP2018536654A (ja) 2018-12-13
ES2873828T3 (es) 2021-11-04
AU2016350219B2 (en) 2021-04-29

Similar Documents

Publication Publication Date Title
AU2021205101B2 (en) Innovative preparation and crystallization of iosimenol
JP5951506B2 (ja) プリン誘導体の結晶性形態
IL265536B (en) Method for producing the crystalline form of modification a of calcobutrol
CN113710648B (zh) 亚稳晶体变体及其制备方法(ii)
EP2896609A1 (en) Crystalline fingolimod citrate for the treatment of relapsing-remitting multiple sclerosis
US9815773B2 (en) Crystalline particles of glutamic acid N,N-diacetic acid
JP6252991B2 (ja) ナファモスタットメシル酸塩の製造方法
HK1257821B (en) Innovative preparation and crystallization of iosimenol
RU2586117C2 (ru) Кристаллизация гидрохлорида эпирубицина
KR20160099655A (ko) 테노포비르의 고체 형태
WO2007074475A2 (en) Novel polymorphic forms of ibandronate
US8410287B2 (en) Hydrated sodium salt form of celecoxib
KR20050033525A (ko) 가바펜틴의 새로운 무수 결정질 형태
TW202409034A (zh) 度洛巴坦（Ｄｕｒｌｏｂａｃｔａｍ）結晶型
JP2022539342A (ja) ｔｅｒｔ－ブチル（Ｓ）－２－（（２Ｓ，３Ｒ）－１－アミノ－３－ヒドロキシ－１－オキソブタン－２－イル）－１－オキソ－２，５－ジアザスピロ［３．４］オクタン－５－カルボキシレートの固体形態およびそれらを調製する方法
US20220048852A1 (en) Process of preparing iosimenol
WO2023242384A1 (en) Crystalline form of ibrutinib
EA044016B1 (ru) Твердые формы трет-бутил(s)-2-((2s,3r)-1-амино-3-гидрокси-1-оксобутан-2-ил)-1-оксо-2,5-диазаспиро[3.4]октан-5-карбоксилата и способы их получения
EP4422755A1 (en) Salt forms of a 4h-pyran-4-one structured cyp11 at inhibitor
KR20120104781A (ko) 글리세릴 포스포릴 콜린의 이형 결정 및 그 제조방법
CN113087680A (zh) Dota晶型及其制备方法

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20211027

FZDE Discontinued

Effective date: 20240328